Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A

Infection and Immunity

Volumn 66, Issue 5, 1998, Pages 2170-2179

  Elzaim, Haissam S ^a   Chopra, Ashok K ^a,b   Peterson, Johnny W ^a,b   Goodheart, Rick ^b   Heggers, John P ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN A ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDE ANTIBODY; PSEUDOMONAS EXOTOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BURN; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVE SITE; EPITOPE MAPPING; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; RABBIT; SEPSIS; STRAIN DIFFERENCE; SURVIVAL RATE;

PSEUDOMONAS AERUGINOSA;

EID: 0031924786     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.5.2170-2179.1998     Document Type: Article

References (45)

1. Allured, V. S., R. J. Collier, and D. B. McKay. 1986. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 angstrom resolution. Proc. Natl. Acad. Sci. USA 83:1320-1324.
2. Beattie, B. K., G. A. Prentice, and A. R. Merrill. 1996. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A. Biochemistry 35:15134-15142.
3. Bryan, C. S., X. L. Reynolds, and E. R. Berner. 1983. Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effect of antimicrobial therapy. Rev. Infect. Dis. 5:629-638.
4. Chaudhary, V. K., Y. H. Xu, D. FitzGerald, S. Adhya, and I. Pastan. 1988. Role of domain II of Pseudomonas exotoxin in the secretion of proteins into the periplasm and medium of Escherichia coli. Proc. Natl. Acad. Sci. USA 85: 2939-2943.
5. Chia, J. K. S., M. Pollack, D. Avigan, and S. Steinbach. 1986. Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A. Infect. Immun. 52:756-762.
6. Chung, D. W., and R. J. Collier. 1977. Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa. Infect. Immun. 16:832-841.
7. Dick, J. D., V. Shull, J. E. Karp, and J. Valentine. 1988. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients. Eur. J. Cancer Clin. Oncol. 25(Suppl. 1):S47-54.
8. Farahbakhsh, Z. T., and B. J. Wisnieski. 1987. The acidic triggered entry pathway of Pseudomonas exotoxin A. Biochemistry 28:580-585.
9. Feigin, R. D., and W. T. Shearer. 1975. Opportunistic infection in children. In the compromised host. J. Pediatr. 87:677-694.
10. Feldman, M. 1996. What is the mechanism of action of anti-tumor necrosis factor alpha antibody in rheumatoid arthritis? Int. Arch. Allergy Immunol. 111:362-365.
11. Furuya, N., Y. Hirakata, K. Tomono, T. Matsumoto, K. Takeda, M. Kaker, and K. Yamaguchi. 1993. Comparison of mortality rates in mice with endogenous septicemia due to Pseudomonas aeruginosa isolates from different clinical sources. J. Med. Microbiol. 39:141-146.
12. Gingeri, A., E. Santagostino, M. Cusini, M. Muca-Perja, A. Marinoni, P. H. Mannucci, A. Burny, M. Griscuolo, W. Lu, J. M. Anderieru, J. P. Mebika, A. Luchgar, L. S. Fall, V. Chams, M. Feldman, P, Hermens, J. F. Zagury, B. Bizzini, M. Musicco, and D. Zagury. 1996. Absence of clinical, virological, immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:55-67.
13. Gray, G. L., D. H. Smith, J. S. Baldridge, R. N. Harkins, M. L. Vasil, E. Y. Chan, and H. L. Heyneker. 1984. Cloning, nucleotide sequence and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 81:2645-2649.
14. Hedberg, M., J. K. Miller, and V. N. Tompkins. 1969. Elastase activity of Pseudomonas aeruginosa isolates from hospital patients. Am. J. Clin. Pathol. 52:631-633.
15. Heggers, J. P., and M. C. Robson (ed.). 1991. Quantitative bacteriology: its role in the armamentarium of the surgeon, 1st ed. CRC Press, Inc., Boca Raton, Fla.
16. Heggers, J. P., S. Haydon, F. Ko, P. G. Hayward, S. Carp, and M. Robson. 1992. Pseudomonas aeruginosa exotoxin A: its role in retardation of wound healing: the 1992 Lindberg award. J. Wound Care Rehabil. 13:512-518.
17. Heggers, J. P., et al. 1996. Treatment of infections in burns, p. 98-135. In D. N. Herndon (ed.), Total burn care. W. B. Saunders Co., Ltd., London, England.
18. Hwang, J., D. J. P. Fitzgerald, S. Adhya, and I. Pastan. 1987. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48:129-136.
19. Iglewski, B. H., and D. Kabat. 1975. NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin. Proc. Natl. Acad. Sci. USA 72: 2284-2288.
20. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 226:680-685.
21. Liu, P. V. 1966. The role of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease. J. Infect. Dis. 116: 112-116.
22. Liu, P. V. 1973. Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. J. Infect. Dis. 128:506-513.
23. Liu, P. V., S. Yoshii, and H. Hsieh. 1974. Exotoxins of Pseudomonas aeruginosa. II. Concentration, purification, and characterization of exotoxin A. J. Infect. Dis. 128:514-519.
24. Liu, P. V. 1974. Extracellular toxins of Pseudomonas aeruginosa. J. Infect. Dis. 130(Suppl.):S94-99.
25. Middlebrook, J. L., and R. B. Dorland. 1977. Response of cultured mammalian cells to the exotoxins of Pseudomonas aeruginosa and Corynebacterium diphtherias: differential cytotoxicity. Can. J. Microbiol. 23:183-189.
26. Misfeldt, M. L., P. X. Legaard, S. E. Howell, M. H. Fornella, and R. D. LeGrand. 1990, Induction of interleukin-1 from murine peritoneal macrophages by Pseudomonas aeruginosa exotoxin A. Infect. Immun. 58:978-982.
27. Moller, P. C., M. J. Evans, R. C. Faden, L. C. Henson, B. Rogers, and J. P. Heggers. 1994. The effect of anti-exotoxin A on the adherence of Pseudomonas aeruginosa to hamster tracheal epithelial cells in vitro. Tissue Cell 26:181-188.
28. Morihara, K. 1964. Production of elastase and proteinase by Pseudomonas aeruginosa. J. Bacteriol. 88:745-757.
29. Nathan, P., I. A. Holder, and B. G. MacMillan. 1973. Burn wounds: microbiology, local host defenses and current therapy. Crit. Rev. Clin. Lab. Sci. 4: 61-100.
30. Ogata, M., I. Pastan, and D. Fitzgerald. 1991. Analysis of Pseudomonas exotoxin activation and conformational changes by using monoclonal antibodies as probes. Infect. Immun. 59:407-414.
31. Olson, J. C., A. N. Hammod, T. S. Vincent, E. H. Beachey, and B. H. Iglewsky. 1990. Identification of functional epitopes of Pseudomonas aeruginosa exotoxin A using synthetic peptides and subclone products. Mol. Immunol. 27:981-993.
32. Polk, H. C. 1979. Consensus summary on infection. J. Trauma 19:894.
33. Pollack, M., and S. E. Anderson, Jr. 1978. Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infect. Immun. 19:1092-1096.
34. Pollack, M., N. S. Taylor, and L. T. Callahan III. 1975. Exotoxin production by clinical isolates of Pseudomonas aeruginosa. Infect. Immun. 15:776-780.
35. Pollack, M. 1983. The role of exotoxin A in disease and immunity. Rev. Infect. Dis. 5:s979-s984.
36. Roscoe, D. M., S.-H. Jung, I. Benhar, L. Pai, B. K. Lee, and I. Pastan. 1994. Primate antibody response to immunotoxin: scrological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin. Infect. Immun. 62:5055-5065.
37. Sabath, L. D. (ed.). 1980. P. aeruginosa, the organism, the diseases it causes, and their treatment, p. 264-280. Hans Huber, Bern, Switzerland.
38. Staugas, R. E. M., D. P. Harvey, A. Ferrante, M. Nandoskar, and A. C. Allison. 1992. Induction of tumor necrosis factor (TNF) and interleukin-1 (IL-1) by Pseudomonas aeruginosa and exotoxin A-induced suppression of lymphoproliferation and TNF, lymphotoxin, gamma interferon, and Il-1 production in human leukocytes. Infect. Immun. 60:3162-3168.
39. Stuart, R. K., and M. Pollack. 1982. Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro, Infect. Immun. 38:206-211.
40. Teplitz, C. 1979. The pathology of burns and the fundamentals of burn wound sepsis, p. 45-94. In C. P. Artz et al. (ed.). Burns: a team approach. W. B. Saunders, Philadelphia, Pa.
41. van Dullemen, H. M., S. J. van Deventer, D. W. Hommes, H. A. Bijl, J. Jansen, G. N. Tytgat, and J. Woody. 1995. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109:129-35.
42. Vasil. M. L., G. L. Gray, and C. C. Grant. 1984. Molecular analysis of the exotoxin A gene of Pseudomonas species, abstr. D70, p. 62. In Abstracts of the 84th Annual Meeting of the American Society for Microbiology 1984. American Society for Microbiology, Washington, D.C.
43. Vymola, F., and O. Lochmann. 1974. Characteristics of Pseudomonas haemolysin. J. Hyg. Epidemiol. Microbiol. Immunol. 18:302-309.
44. Young, L. S., P. Stevens, and B. Kaijser. 1982. Gram-negative pathogens in septicemia infections. Scand. J. Infect. Dis. 31:78-94.
45. Zeggers, N., K. Gerritse, C. Deen, W. Boersma, and E. Claasen. 1990. An improved conjugation method for controlled covalent coupling of synthetic peptides to proteins using glutaraldehyde in dialysis method. J. Immunol. Methods 130:195-200.